Terkko Navigator / Hematology/ Feeds

Monoclonal antibodies for the treatment of COVID‐19 in a patient with high‐risk acute leukaemia

Minimal residual disease (MRD) detection in acute lymphoblastic leukaemia based on fusion genes and genomic deletions: towards MRD for all

Proteomic analysis and microRNA expression profiling of plasma‐derived exosomes in primary immune thrombocytopenia

The incidence and type of cancer in patients with ataxia‐telangiectasia via a retrospective single‐centre study

Correction to: Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study

Targeting serine hydroxymethyltransferases 1 and 2 for T-cell acute lymphoblastic leukemia therapy

Plasma, platelet and red blood cell transfusion ratios for life‐threatening non‐traumatic haemorrhage in medical and post‐surgical patients: An observational study

An abdominal mass with thrombosis due to inferior vena cava agenesis mimicking lymphoma

3D migration of human amniotic fluid stem cells involves mesenchymal and amoeboid modes and is regulated by mTORC1

Statin use and survival in 16 098 patients with non‐Hodgkin lymphoma or chronic lymphocytic leukaemia treated in the rituximab era

Updated results of the placebo‐controlled, phase III JAKARTA trial of fedratinib in patients with intermediate‐2 or high‐risk myelofibrosis

Undetectable minimal residual disease is an independent prognostic factor in splenic marginal zone lymphoma

Reply to Farrugia: Appropriately specifying the quality of plasma for fractionation

The secreted tyrosine kinase VLK is essential for normal platelet activation and thrombus formation

Murine bone marrow mesenchymal stromal cells have reduced hematopoietic maintenance ability in sickle cell disease

Validation of the IMWG standard response criteria in the PETHEMA/GEM2012MENOS65 study: are these times of change?

Appropriately specifying the quality of plasma for fractionation

Development of antibody response to SARS‐CoV‐2 following asymptomatic infection in patients with plasma cell disorders on immunomodulatory therapy

Microvesicles, but not platelets, bud off from mouse bone marrow megakaryocytes

Immune cells surveil aberrantly sialylated O-glycans on megakaryocytes to regulate platelet count

Requirements for operational cure in multiple myeloma

An erythroid to myeloid cell fate conversion is elicited by LSD1 inactivation

Crystal-storing histiocytosis associated with smoldering myeloma

B cells: fed and grown in the bone

Understanding VITT(ual) reality

A "Goldilocks" approach to CNS leukemia is needed

Novel mechanism regulating tissue factor activity

Vaccine-induced immune thrombotic thrombocytopenia: what we know and do not know

Prothrombotic immune thrombocytopenia after COVID-19 vaccination

CD70-specific CAR T cells have potent activity against acute myeloid leukemia without HSC toxicity

Neuroimmune interactions in painful TMD: Mechanisms and treatment implications

Decreased levels of immune‐regulatory cytokines in patients with immune thrombocytopenia and long‐lasting overexpression of these cytokines in the splenectomized patients

Response to mRNA vaccination for COVID-19 among patients with multiple myeloma

Small molecule inhibition of deubiquitinating enzyme JOSD1 as a novel targeted therapy for leukemias with mutant JAK2

CEBPA Mutations in 4708 Patients with Acute Myeloid Leukemia - Differential Impact of bZIP and TAD Mutations on Outcome

A STAT5B-CD9 axis determines self-renewal in hematopoietic and leukemic stem cells

BCL2 inhibitors and MCL1 inhibitors for hematological malignancies

Resistance to Bruton's Tyrosine Kinase Inhibitors: The Achilles Heel of Their Success Story in Lymphoid Malignancies

High-dose AraC is Essential for the Treatment of ML-DS Independent of Post-Induction MRD: Results of COG AAML1531

Targeting B-cell receptor and PI3K signaling in diffuse large B-cell lymphoma

Introduction to a review series on small molecule targeted therapies for lymphoid malignancies

Time–temperature indicators versus temperature indicators for transfusion practice: Application in the real hospital setting

Comparison between tube test and automated column agglutination technology on VISION Max for anti‐A/B isoagglutinin titres: A multidimensional analysis

Acquired elliptocytosis in a patient with myelodysplastic syndrome harbouring a novel unbalanced whole‐arm translocation, der(14;20)(q10;p10)

Graft‐versus‐host disease induced by tisagenlecleucel in patients after allogeneic stem cell transplantation

Haemophilia: factoring in new therapies

A nationwide survey on central nervous system multiple myeloma in Japan: analysis of prognostic and treatment factors that impact survival

MiR‐22, a serum predictor of poor outcome and therapy response in diffuse large B‐cell lymphoma patients

The RNA-binding protein IGF2BP3 is critical for MLL-AF4-mediated leukemogenesis

Improving the investigative approach to polycythaemia vera: a critical assessment of current evidence and vision for the future